Multichannel Marketing in Healthcare

In healthcare, digital engagement isn’t a channel challenge. It’s an orchestration challenge. That’s why two strategic models are shaping the future of digital patient experience: 🔁 𝗢𝗺𝗻𝗶𝗰𝗵𝗮𝗻𝗻𝗲𝗹 delivers one continuous experience across all channels — app, SMS, portal, nurse call — with context and conversation intact. 🎯 𝗢𝗽𝘁𝗶𝗰𝗵𝗮𝗻𝗻𝗲𝗹 refines that foundation by using data and AI to select the best channel for the moment, message, and individual. These aren’t competing strategies. They work best together. Omnichannel ensures continuity. Optichannel delivers precision. The result? A journey that’s connected, context-aware, and personalized without being overwhelming. 🔁 𝗢𝗺𝗻𝗶𝗰𝗵𝗮𝗻𝗻𝗲𝗹: 𝗧𝗵𝗲 𝗳𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗮 𝘀𝗲𝗮𝗺𝗹𝗲𝘀𝘀 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 Done well, omnichannel turns fragmented touchpoints into a single conversation — wherever the patient shows up. 𝗧𝗵𝗲 𝗽𝗿𝗶𝗻𝗰𝗶𝗽𝗹𝗲𝘀: 🧩 Unified data across touchpoints 🔄 Consistent messaging and tone 💬 Smooth transitions with no repeated questions or conflicting info 𝗧𝗵𝗲 𝗽𝗮𝘆𝗼𝗳𝗳: ✅ 89% retention in well-orchestrated support programs ✅ 23% increase in adherence when channels reinforce each other ✅ 3× more likely to follow care plans when communication is cohesive (Source: MedAdvisor, 2025) It’s not about being everywhere. It’s about ensuring the patient never feels lost, no matter where they are. Unified omnichannel systems also reduce privacy risk and simplify compliance — fewer silos, fewer handoffs, lower exposure. 🎯 𝗢𝗽𝘁𝗶𝗰𝗵𝗮𝗻𝗻𝗲𝗹: 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗼𝗻 𝘁𝗼𝗽 𝗼𝗳 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗶𝘁𝘆 Where omnichannel brings everything together, optichannel chooses wisely. It uses AI-powered patient-level insights to ask: What’s the best channel for this patient, right now? 📲 Simple reminder? Send an SMS. 📞 Side effect concern? Route to a nurse call — with context in hand. 🔁 Disengagement risk? Slow the cadence. Shift the tone. Adapt the medium. Optichannel avoids noise and delivers fewer, more effective touches — without sacrificing personalization. Because in healthcare, behavior isn’t driven by more messages. It’s driven by meaningful continuity and personalized context. 𝗛𝗼𝘄 𝗶𝘀 𝘆𝗼𝘂𝗿 𝘁𝗲𝗮𝗺 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗶𝗻𝗴 𝘁𝗵𝗲 𝗯𝗮𝗹𝗮𝗻𝗰𝗲 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗰𝗼𝘃𝗲𝗿𝗮𝗴𝗲 𝗮𝗻𝗱 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗼𝗻? Let’s compare notes.

Pharmaceutical and medical device companies face unique challenges in connecting with HCPs, patients, and stakeholders. As traditional marketing methods become less effective and privacy concerns grow, first-party data emerges as a game-changer for our industry. First-party data—information collected directly from customers with their consent—is becoming increasingly crucial for success in digital marketing. With the impending phase-out of third-party cookies, leveraging your own data will be more important than ever. But how can pharma and medical device companies harness the full potential of first-party data? A study by Boston Consulting Group (BCG) and Google revealed that while data-driven marketing can double revenue and increase cost savings by 1.6 times, only about 30% of companies are creating a single customer view across channels. Even more striking, just 1-2% are using data to deliver a full cross-channel experience for their customers. To bridge this gap and gain a competitive edge, industry leaders need to focus on three key actions: 1. Develop a Comprehensive Data Strategy - Instead of collecting data indiscriminately. This might involve prioritizing data from healthcare provider interactions, patient support programs, or clinical trial participants. Assess the value of your first-party data rigorously. Calculate associated costs and risks and develop a clear implementation roadmap. This approach not only streamlines your efforts but also helps secure buy-in from executives—crucial for successful implementation. 2. Test, Learn, and Measure - Start with a specific business case for your data. For instance, you might aim to improve adherence to a particular treatment or increase adoption of a new medical device. Define what needs to be personalized to achieve this goal. While one-to-one personalization might seem ideal, it requires significant investment and time. Focus on a narrow use case—perhaps a specific physician specialty or patient segment—and invest only in the data and technology required to test that particular case. 3. Build Robust In-House Tech Capabilities - Traditionally, pharma and medical device companies have heavily relied on agencies for marketing efforts. However, a hybrid approach may be more effective in the age of first-party data. Consider insourcing your technology stack and capabilities related to data analysis and activation. At the same time, leverage agencies for their strategic perspective, creative content, and media buying expertise. Many agencies are evolving to meet these changing needs, offering everything from à la carte services for mature brands to turnkey solutions for those just starting their data journey. By focusing on these three areas, pharmaceutical and medical device companies can unlock the full potential of their first-party data. This not only improves the customer experience, but also boosts business results. #CXStrategy #pharmaceuticals #medicaldevices #DataStrategy

"𝗔𝗻𝗼𝘁𝗵𝗲𝗿 𝗴𝗲𝗻𝗲𝗿𝗶𝗰 𝗲𝗺𝗮𝗶𝗹 𝗮𝗯𝗼𝘂𝘁 𝘆𝗼𝘂𝗿 𝗱𝗿𝘂𝗴?"  𝘋𝘦𝘭𝘦𝘵𝘦. Your perfectly crafted message just joined thousands of others in a doctor's trash folder. Reps and MSLs spend 60% of their time on admin instead of building the relationships that matter. Healthcare professionals are drowning in noise. And everyone's losing. When engagement isn't personalized, everyone loses. HCPs miss critical information that could impact patient care. Sales teams waste time on low-value activities. Meanwhile, competitors who adapt faster are winning mindshare and trust. But what if AI could transform each interaction from 𝘨𝘦𝘯𝘦𝘳𝘪𝘤 to 𝘨𝘦𝘯𝘪𝘶𝘴? It's already happening: A global team uses an AI powered omnichannel platform to tune content and outreach for each HCP in real time. The system watches what each HCP actually clicks and when they prefer to learn. It notices formats too. Articles. Webinars. Short summaries. Case studies. If a cardiologist reads real-world evidence late at night and ignores promos, the platform suppresses standard emails. It serves non-promotional insights instead. It lines up invites to medical webinars that fit their schedule. It keeps the focus on value. For each HCP, the AI drafts instant clinical briefs and suggests a next best action for the rep or MSL. That might be a follow up call on the practical use of a new therapy. Or a peer-reviewed paper on a topic they've shown interest in. Reps and MSLs see dynamic, prioritized call lists with context cards. Recent activity. Preferred times. Content consumed. Suggested openers. They show up relevant and right on time. Chatbots answer common questions 24/7. That reduces repetitive in-person detailing and clears the runway for deeper talks. Does this replace reps or MSLs? No. It upgrades them: • Less admin. More science and trust. • AI finds the signal. Humans bring judgment and nuance. • Field teams decide what matters for this patient, this clinic, today. • Feedback from the field teaches the system what good looks like. The loop gets smarter. Teams using this approach report: • 3x faster information delivery • 78% higher HCP engagement rates • 92% of reps saying relationships are stronger 𝗧𝗵𝗲 𝗔𝗜 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗶𝗻 𝗽𝗵𝗮𝗿𝗺𝗮 𝗲𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗶𝘀𝗻'𝘁 𝗰𝗼𝗺𝗶𝗻𝗴. 𝗜𝘁'𝘀 𝗵𝗲𝗿𝗲.  Look at what industry leaders are already achieving: • 𝗡𝗼𝘃𝗮𝗿𝘁𝗶𝘀 transformed their commercial model, achieving 2x better HCP engagement with AI-guided timing • 𝗠𝗲𝗿𝗰𝗸 reduced sales rep admin tasks by 30% through AI automation • A 𝘁𝗼𝗽-𝟭𝟬 𝗽𝗵𝗮𝗿𝗺𝗮 doubled their email open rates with AI-powered smart timing 𝘈𝘯𝘥 𝘵𝘩𝘪𝘴 𝘪𝘴 𝘫𝘶𝘴𝘵 𝘵𝘩𝘦 𝘣𝘦𝘨𝘪𝘯𝘯𝘪𝘯𝘨. 𝗪𝗵𝗮𝘁'𝘀 𝘆𝗼𝘂𝗿 𝘁𝗮𝗸𝗲? 🔄 How do you think this will change the rep-HCP relationship? 𝘚𝘩𝘢𝘳𝘦 𝘺𝘰𝘶𝘳 𝘵𝘩𝘰𝘶𝘨𝘩𝘵𝘴 𝘣𝘦𝘭𝘰𝘸. 𝘈𝘴 𝘴𝘰𝘮𝘦𝘰𝘯𝘦 𝘪𝘯 𝘵𝘩𝘦 𝘵𝘳𝘦𝘯𝘤𝘩𝘦𝘴, 𝘺𝘰𝘶𝘳 𝘱𝘦𝘳𝘴𝘱𝘦𝘤𝘵𝘪𝘷𝘦 𝘮𝘢𝘵𝘵𝘦𝘳𝘴.

Pharma spent $19.45 billion on digital HCP advertising in 2025. Here's what that money actually bought: The average HCP receives 3,200+ digital communications annually. They engage with less than 2.5%. Oncologists alone get 152 display ads per month on personal devices. Plus 9 rep visits per day. And only 33% of clinicians are "digitally enthusiastic." The rest are overwhelmed, skeptical, or tuning out entirely. But here's what almost nobody talks about: The most expensive channels aren't the most effective. 𝗧𝗵𝗲 𝟮𝟬𝟮𝟱 𝗛𝗖𝗣 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 𝗥𝗢𝗜 𝗥𝗮𝗻𝗸𝗶𝗻𝗴 (𝗕𝘆 𝗔𝗰𝘁𝘂𝗮𝗹 𝗘𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀, 𝗡𝗼𝘁 𝗩𝗲𝗻𝗱𝗼𝗿 𝗖𝗹𝗮𝗶𝗺𝘀): 𝟭. 𝗧𝗿𝗶𝗴𝗴𝗲𝗿𝗲𝗱 𝗘𝗺𝗮𝗶𝗹 → $36 ROI per $1 spent. 18.26% open rate vs broadcast. Engagement up 47% YoY. 𝟮. 𝗣𝗼𝗶𝗻𝘁 𝗼𝗳 𝗖𝗮𝗿𝗲 (𝗣𝗢𝗖) → Grew 171% since 2019. Now a $1B+ industry. Reaches HCPs at the decision moment. 𝟯. 𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗢𝗺𝗻𝗶𝗰𝗵𝗮𝗻𝗻𝗲𝗹 → 10.5% script lift. 7.4:1 ROI. Predictive targeting actually works. 𝟰. 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗖𝗼𝗻𝘁𝗲𝗻𝘁 → 67% higher engagement. 47% higher prescribing likelihood. 𝟱. 𝗘𝗛𝗥/𝗪𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝗠𝗲𝘀𝘀𝗮𝗴𝗶𝗻𝗴 → Meets HCPs where they already are. High trust, low friction. 𝟲. 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗗𝗲𝘁𝗮𝗶𝗹𝗶𝗻𝗴 → Fills access gaps. Scales better than field. 𝟳. 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲𝘀 → High-value KOL touchpoints. But expensive per contact. 𝟴. 𝗙𝗶𝗲𝗹𝗱 𝗦𝗮𝗹𝗲𝘀 𝗥𝗲𝗽𝘀 → $260K-$450K per rep annually. Only 32% of oncologists fully accessible. Still matters for complex therapies. 𝟵. 𝗣𝗿𝗼𝗴𝗿𝗮𝗺𝗺𝗮𝘁𝗶𝗰 𝗗𝗶𝘀𝗽𝗹𝗮𝘆 → HCP digital display spend down 22%. Saturation killed effectiveness. 𝟭𝟬. 𝗕𝗿𝗼𝗮𝗱𝗰𝗮𝘀𝘁 𝗘𝗺𝗮𝗶𝗹 𝗕𝗹𝗮𝘀𝘁𝘀 → Lowest engagement. Highest unsubscribe. Still overused. 𝗧𝗵𝗲 𝟮𝟬𝟮𝟬 → 𝟮𝟬𝟮𝟱 𝗦𝗵𝗶𝗳𝘁: → Digital usage: 92.5% → 96.2% → POC marketing: +171% → HCP display ads: -22% → Field access: Declining fast COVID accelerated digital adoption. But it also accelerated digital fatigue. 𝗜𝗳 𝗬𝗼𝘂 𝗛𝗮𝗱 $𝟭𝗠 𝘁𝗼 𝗥𝗲𝗮𝗰𝗵 𝗛𝗖𝗣𝘀: → $300K: Triggered email + personalization → $250K: Point of Care → $200K: AI-powered omnichannel orchestration → $150K: EHR/workflow messaging → $100K: Strategic field rep deployment (high-value targets only) 𝗪𝗵𝗲𝗿𝗲 𝗣𝗵𝗮𝗿𝗺𝗮 𝗢𝘃𝗲𝗿𝘀𝗽𝗲𝗻𝗱𝘀: → Display ads that nobody clicks → Broadcast emails that get deleted → Field reps visiting inaccessible physicians 𝗪𝗵𝗲𝗿𝗲 𝗣𝗵𝗮𝗿𝗺𝗮 𝗨𝗻𝗱𝗲𝗿𝘀𝗽𝗲𝗻𝗱𝘀: → Triggered, behavior-based email → Point of Care at the decision moment → Clean, verified HCP data that makes everything else work The $19.45B question isn't how much you spend. It's whether you're spending it where HCPs actually pay attention. We study HCP engagement at a depth most teams never get to see. 😁

A health tech startup just raised $10M in Series A. They came to me and asked, “How should we spend $2M on marketing?” Here’s what I told them - and what most startups get completely wrong: 🔹 40% – Content + Thought Leadership ($800K) Not blogs. Executive ghostwriting. Industry reports. Podcast sponsorships. Speaking slots at top conferences. In healthcare, authority > ads. 🔹 25% – Account-Based Marketing ($500K) Target 200 specific orgs. Custom content per persona. Direct mail + exec dinners. This isn’t SaaS - it’s relationship selling. 🔹 20% – Sales Enablement ($400K) ROI calculators, case studies, reference programs. Your reps don’t just need leads. They need ammo. 🔹 10% – Paid Media ($200K) LinkedIn, industry pubs, retargeting. Small budget here - healthcare execs don’t click banner ads. 🔹 5% – Tools + Tech ($100K) CRM, automation, analytics, video gear. The backend matters. Remember, you’re not buying attention. You’re building trust. And most startups don’t know how to do that. If you're sitting on budget and unsure how to make it move the needle - let's talk 😎 #HealthTech #MarketingBudget #GTM #MarketingStrategy #ContentStrategy #DigitalHealth

Think like a patient. The best healthcare advice keeps things human. Connected care is not just about tech. Let’s break down what’s really changing in the UAE and KSA. → Generative AI is everywhere. Fifty-eight percent of people now use tools like ChatGPT or Gemini. Many use them every day. They ask questions, check symptoms, and get health tips in seconds. → Devices are multiplying. It’s not just phones. People want smartwatches, fitness bands, and home monitors. They want to track their health, not just read about it. → Social media is the new waiting room. Seventy-three percent of people buy things through social media. They trust influencers. They follow health tips from people they like. They book appointments and join health groups online. → Privacy and cost matter more than ever. One in four people worry about their data. Subscription fatigue is real. People want to know their health info is safe. They want fair prices, not hidden fees. So, what does this mean for hospitals and clinics? → AI can help, but only if people trust it. Chatbots and virtual assistants can answer questions fast. But if people don’t trust the answers, they won’t use them. Data privacy and accuracy must come first. → Wearables bring care home. Smart devices can track blood pressure, sugar, or heart rate. Doctors can check on patients without a hospital visit. This helps people with chronic illness or after surgery. → Social channels are now health channels. Hospitals can use social media to teach, book visits, and build community. Trusted voices can guide people to better choices. → Ethics and fairness are not optional. With so much tech, mistakes can happen. Misinformation spreads fast. Hospitals must be open about how they use data. They must check every tool for safety. They must keep care affordable. Here’s how to get it right: • Build trust with clear rules for data and AI. • Design every tool for real people, not just tech fans. • Mix in-person, virtual, and home care for the best results. • Work with tech companies and regulators to set high standards. The future of care is not just digital. It’s about meeting people where they are. It’s about trust, safety, and real connection. That’s how connected care will truly change lives in the region. Study link: https://lnkd.in/eaUeA9S8

We launched ecommert Navigator report on Nov 13th, and now we continue with our category-focused insights and analyses, on consumer health care (CHC). You can download the full report using the link in the comments. In this first edition of our Category & Channel Insights, we deep-dive and analyze the Consumer Health Care (CHC). The CHC category's growth in eCommerce is driven by several key factors, including advancements in digital health platforms, increased consumer reliance on online channels for health-related products, and significant retailer investments in retail media networks (RMNs). ++ 𝗞𝗲𝘆 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 𝗼𝗳 𝗲𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗲 𝗚𝗿𝗼𝘄𝘁𝗵 𝗶𝗻 𝗖𝗛𝗖 ++ - Shift to Online Retail: - Retail Media Networks (RMNs) - Digital Shelf Optimization - Increased Consumer Health Awareness - Advanced Data Analytics and Targeting ++ 𝗧𝗮𝗰𝘁𝗶𝗰𝗮𝗹 𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗖𝗣𝗚 𝗕𝗿𝗮𝗻𝗱𝘀 ++ 1. Prioritize Digital Shelf Readiness: Investing in "retail readiness" enhances discoverability and conversion. 2. Leverage Retail Media Networks: Collaborate with RMNs to target health-conscious shoppers effectively. 3. Expand Direct-to-Consumer Channels: Build robust DTC platforms to capture insights and foster deeper consumer relationships. 4. Capitalize on Consumer Trends: Highlight product benefits aligned with trends like immunity, mental wellness, and fitness. Tailored messaging through social commerce (e.g., TikTok) can reach younger, health-conscious demographics. 5. Adopt Advanced Analytics: Assess competitive benchmarks to refine pricing and promotional strategies. 6. Integrate Omnichannel Strategies: Blend online and offline campaigns for a seamless consumer experience. For instance, use data from in-store purchases to target online ads and vice versa. ++ 𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝗔𝗵𝗲𝗮𝗱: 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗶𝗻 𝗖𝗛𝗖 𝗲𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗲 ++ 📍Personalized Health Solutions: Brands should innovate with customizable supplements and health products delivered through subscription models. 📍Collaborations with Telehealth Platforms: Partnerships with digital health services can create bundled offerings of products and services. 📍Global Expansion: Target regions with emerging eCommerce ecosystems like Southeast Asia and Latin America for CHC growth. 𝗧𝗼 𝗮𝗰𝗰𝗲𝘀𝘀 𝗮𝗹𝗹 𝗼𝘂𝗿 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀, 𝗳𝗼𝗹𝗹𝗼𝘄 𝗲𝗰𝗼𝗺𝗺𝗲𝗿𝘁®, 𝘀𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲 𝘁𝗼 𝗼𝘂𝗿 𝟭𝟬,𝟲𝟬𝟬+ 𝘀𝘁𝗿𝗼𝗻𝗴 𝗻𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿 𝗮𝗻𝗱 𝗱𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁 👇 Kenvue Haleon Sanofi Bayer | Consumer Health Bayer Reckitt Vytalogy Wellness Perrigo Company plc Lupin STADA Group Taisho Pharmaceutical Holding Co Ltd Daiichi Sankyo US Eczacıbaşı Topluluğu Abdi Ibrahim Pharmaceuticals #CPG #FMCG #CHC #eCommerce #omnichannel

Been chatting with a lot of healthcare CMOs & Marketing VPs lately and I can tell you the biggest issues they're struggling with: 1) Trust Crisis Consumer dissatisfaction with healthcare is thru the roof. Front office issues are pushing patients away and pushing more orgs to think about how AI can replace some of those bottlenecks. A lot of patients are also disillusioned with random search results> no one knows if the AI summary is actually true. Even with the non-AI stuff there's no guarantee it's written by a knowledgeable provider. Also why we're seeing a bump in influencer marketing> people gravitate to voices they trust. Gotta put in the effort to become one of those voices. More authored pieces featuring your physicians, more short-form video from your staff that feels authentic, patient-generated content if you can. 2) Consumer Search Behavior Google is still dominant but we're long past the days when being in the top few Google results was the only thing you needed. A lot of decisions are being influenced by the upper funnel and marketers have expanded to Meta, PMAX, CTV, OTT, and now TikTok as a result. People search there too. Healthcare consumers now shop for healthcare like retail> gotta appeal to the savvy consumers with a good USP, positive brand feelings, and a UX as good as Uber. 3) Multi-Channel Attribution Expanding into so many new channels means we need to be able to track the ROI on them - but that's easier said than done. Last-touch attribution doesn't get the job done. Multi-touch attribution is great in theory but difficult to do these days especially with so many walled gardens. Piwik and Mixpanel allow HIPAA compliant MTA but only click based, impression based nearly impossible in healthcare. 4) Leadership Turnover Half of all healthcare execs say they might leave within the next year. Makes marketing's job of aligning with the C-suite a lot harder if the occupants of that suite keep changing. But I've yet to meet the CEO who wasn't primarily concerned with patient volume. So my advice to marketers would be to refocus on what actually drives patient volume so whenever a new CEO shows up you can show them from day one how you're driving patient volume and what it costs. 5) Uncertainty We marketers are an adaptable bunch. Throw us a curveball like new HIPAA regulations or changing Meta restrictions and we'll deal with it. Economic uncertainty driven by random tariffs and funding cuts with little warning makes it very difficult to have confidence in the budget. But the marketing must go on. We learned from Covid that when the economy is down you have to optimize the hell out of the bottom funnel> perfect time to ramp up CVR rather than ad spend. These feel like the Top Half-Dozen Issues of Healthcare Marketing right now. How are you guys handling them? #HealthcareMarketing

If I had to guess, your marketing team is probably spending WAY too much time creating content and not enough time figuring out how to get it in front of the right eyeballs. Creating engaging health tech content is only half the battle (honestly, maybe even less). You need a solid channel plan that meets healthcare leaders where they are and in places they like to be. Here's what I mean... Your CFO audience might prefer shorter content, but they want to see it endorsed by established industry sources they trust. Meanwhile, clinical buyers are over here like "just show me the demo!" And then there's distribution. You can write the best whitepaper in the world, but if you're just posting it on your website and hoping your targets just happen to find it... good luck. Instead, you need to: 👉🏻 Find the "watering holes" – Where do your decision-makers actually hang out? (Think Beckers, HFMA, specific LinkedIn groups for hospital leaders, etc.) 👉🏻 Build credibility through peer validation – Hospital leaders trust their peers more than your marketing. Get your customers talking about you in their circles. 👉🏻 Match the channel to the message – Different content types work better on different platforms. Don't try to force-fit your case study into a tweet if that's not where your audience is looking for that info. The reality? Most health tech companies are just cranking out blogs and social posts without a real distribution strategy. Start by understanding where your buyers get their information. Then build your channel plan FIRST and let that guide your content creation – not the other way around. Need help figuring out your channel strategy? Drop me a DM. Let's map out where your content should actually live.